Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2009-1-21
pubmed:abstractText
In light of the poor prognosis for cervical cancer, research continues into the development of innovative and efficacious treatment modalities for this disease. We investigated the role of hepatocyte growth factor activator inhibitor-2 (HAI-2) and evaluated its clinical importance in cervical cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1569-8041
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
63-70
pubmed:dateRevised
2009-8-10
pubmed:meshHeading
pubmed-meshheading:18689863-Adenocarcinoma, pubmed-meshheading:18689863-Adult, pubmed-meshheading:18689863-Aged, pubmed-meshheading:18689863-Apoptosis, pubmed-meshheading:18689863-Carcinoma, Adenosquamous, pubmed-meshheading:18689863-Carcinoma, Squamous Cell, pubmed-meshheading:18689863-Cell Proliferation, pubmed-meshheading:18689863-Female, pubmed-meshheading:18689863-HeLa Cells, pubmed-meshheading:18689863-Humans, pubmed-meshheading:18689863-Membrane Glycoproteins, pubmed-meshheading:18689863-Middle Aged, pubmed-meshheading:18689863-Prognosis, pubmed-meshheading:18689863-Signal Transduction, pubmed-meshheading:18689863-Transfection, pubmed-meshheading:18689863-Tumor Cells, Cultured, pubmed-meshheading:18689863-Tumor Markers, Biological, pubmed-meshheading:18689863-Uterine Cervical Neoplasms
pubmed:year
2009
pubmed:articleTitle
Hepatocyte growth factor activator inhibitor-2 (HAI-2) is a favorable prognosis marker and inhibits cell growth through the apoptotic pathway in cervical cancer.
pubmed:affiliation
Department of Obstetrics and Gynecology, Okayama University Graduate School of Medical, Dentistry and Pharmaceutical Sciences, Okayama, Japan. k-nakamu@cc.okayama-u.ac.jp
pubmed:publicationType
Journal Article